Skip to main content
Medical information Clinical review pending

Cytogenetics

Chimerism Split Cell Analysis Myeloid Cell CD15 Test

Monitors bone marrow transplant success by measuring donor cell presence in the blood. Essential for post-transplant patient care.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
4 ml (2 ml minimum) whole blood or bone marrow collected in a Lavender Top (EDTA) tube.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Ensure the date of the bone marrow transplant is clearly indicated on the request form.
Test priceKSh 21,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Chimerism Split Cell Analysis Myeloid Cell CD15 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Post-bone marrow transplantation monitoring
  • ✓Suspected graft rejection
  • ✓Suspected relapse of underlying disease
  • ✓Evaluation of transplant engraftment
  • ✓Monitoring patients with unexplained symptoms post-transplant
02

In plain language

What this test helps you understand

This test is used to assess the success of bone marrow transplantation by quantifying the percentage of donor cells (chimerism) in the patient's blood or bone marrow. It helps monitor for graft rejection, relapse of the underlying disease, or other complications following transplantation.
The Chimerism Split Cell Analysis Myeloid Cell CD15 Test is a specialized diagnostic tool used to monitor patients after bone marrow transplantation. It helps determine the proportion of donor cells versus the patient's original cells in the bloodstream. This information is crucial for assessing the transplant's success and guiding further medical decisions. The test specifically looks at myeloid cells expressing CD15. Understanding chimerism, the presence of cells from two different genetic origins in one individual, is vital for managing patients post-transplant. This test provides key data for oncologists to evaluate the effectiveness of the transplant and identify potential issues like graft rejection or disease relapse early on. It is recommended for patients who have undergone bone marrow transplantation, especially if they are experiencing symptoms or are under close monitoring.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Ensure the date of the bone marrow transplant is clearly indicated on the request form.
Sample4 ml (2 ml minimum) whole blood or bone marrow collected in a Lavender Top (EDTA) tube.
MethodologyFlow cytometry is typically used to identify and quantify myeloid cells expressing CD15, differentiating between donor and recipient cells.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Results must be interpreted in the clinical context of the patient's overall condition and treatment history. This test measures chimerism in the specific sample provided and may not reflect the entire body. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Chimerism refers to the presence of cells from two or more genetically distinct individuals within a single person. In the context of bone marrow transplant, it means having both the patient's original cells and the donor's cells.
This test helps doctors understand how well the transplant is working by measuring the percentage of donor cells. It's crucial for monitoring the success of the transplant and detecting potential problems early.
The test measures the proportion of myeloid cells (a type of white blood cell) that express CD15, allowing us to determine the percentage of donor cells compared to the patient's own cells.
A sample of whole blood or bone marrow is needed. It should be collected in a specific type of tube (Lavender Top/EDTA) and sent to the lab refrigerated.
Turnaround time varies. Please contact the laboratory for specific details regarding this test.
Your doctor will interpret the results in the context of your medical history and overall health. Discuss the results and any necessary follow-up steps with your healthcare provider.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp